PROVIDER PROFILE · NPI 1407881592

Kiran NaqviM.D.

PRACTICEUC REGENTSSee all providers at this practice →

Hematology-OncologyOrange, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

117

Unique beneficiaries

—

Total services

478

Distinct HCPCS

Medicare payment

$53K

Peer benchmark

Total Medicare services vs. 957 Hematology-Oncology providers in CA — bottom quintile (cohort median 4,173).

PRESCRIBING · PART D · 2024

Total Rx claims

383

Beneficiaries

—

Total drug cost

$725K

Distinct drugs

Brand share

16.2%

Top prescribed drugs

Acyclovir70 claims

Levofloxacin62 claims

Posaconazole49 claims

Venetoclax31 claims

Ponatinib Hcl31 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

83.7

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Kiran Naqvi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER	12	45

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history